| 2026 |
| 03/06 | 11:00 ヒト(同種)iPS細胞由来心筋細胞シートの条件及び期限付き製造販売承認の取得について |
| 03/06 | 7,280 | 7,980 | 6,880 | 7,200 | -1.37% | 1,326,100 | 595億3014万 | -14.63% |
| 03/05 | 7,190 | 7,410 | 7,040 | 7,300 | +6.73% | 300,000 | 603億5695万 | -13.73% |
| 03/04 | 6,480 | 7,040 | 6,480 | 6,840 | +1.48% | 503,700 | 565億5363万 | -19.4% |
| 03/03 | 7,450 | 7,460 | 6,740 | 6,740 | -8.3% | 487,400 | 557億2683万 | -21.01% |
| 03/02 | 7,630 | 7,790 | 7,330 | 7,350 | -9.03% | 635,200 | 607億7035万 | -14.34% |
| 02/27 | 7,750 | 8,080 | 7,660 | 8,080 | +6.32% | 446,500 | 668億605万 | -5.93% |
| 02/26 | 7,400 | 7,950 | 7,340 | 7,600 | +4.11% | 673,700 | 628億3737万 | -11.19% |
| 02/25 | 7,380 | 7,700 | 7,210 | 7,300 | +0.97% | 737,300 | 603億5695万 | -14.88% |
| 02/24 | 7,870 | 7,900 | 7,150 | 7,230 | -13.1% | 1,202,700 | 597億7818万 | -16.14% |
| 02/20 | 11,240 | 11,830 | 8,210 | 8,320 | -24.02% | 3,380,100 | 687億6784万 | -3.85% |
| 02/19 | 20:00 ヒト(同種)iPS細胞由来心筋細胞シートの製造販売承認審査の状況について |
| 02/19 | 12,080 | 12,400 | 10,800 | 10,950 | -7.75% | 730,700 | 905億575万 | +26.36% |
| 02/18 | 11,100 | 12,300 | 10,800 | 11,870 | +5.32% | 681,100 | 981億989万 | +38.8% |
| 02/17 | 11,460 | 11,830 | 10,420 | 11,270 | +2.92% | 710,900 | 931億5067万 | +34.44% |
| 02/16 | 10,650 | 10,950 | 10,290 | 10,950 | +15.87% | 368,100 | 905億575万 | +33.18% |
| 02/13 | 16:00 ヒト(同種) iPS細胞由来心筋細胞シートに関する部会議題掲載のお知らせ |
| 02/13 | 15:30 営業外収益の計上に関するお知らせ |
| 02/13 | 15:30 通期連結業績予想の修正に関するお知らせ |
| 02/13 | 15:30 2026年3月期第3四半期決算説明資料 |
| 02/13 | 15:30 2026年3月期第3四半期決算短信〔日本基準〕(連結) |
| 02/13 | 8,370 | 9,840 | 8,200 | 9,450 | +11.7% | 772,300 | 781億770万 | +17.09% |
| 02/12 | 8,550 | 8,650 | 8,440 | 8,460 | -1.74% | 142,300 | 699億2499万 | +6.28% |
| 02/10 | 8,320 | 8,670 | 8,260 | 8,610 | +2.74% | 178,300 | 711億6480万 | +9.1% |
| 02/09 | 8,300 | 8,400 | 8,190 | 8,380 | +1.95% | 132,400 | 692億6376万 | +7.49% |
| 02/06 | 16:15 関西財界セミナー2026「特別賞」受賞のお知らせ |
| 02/06 | 8,230 | 8,260 | 8,100 | 8,220 | +0.24% | 112,200 | 679億4130万 | +6.73% |
| 02/05 | 8,150 | 8,360 | 8,070 | 8,200 | 0% | 96,800 | 677億7600万 | +7.58% |
| 02/04 | 8,230 | 8,440 | 8,090 | 8,200 | -1.32% | 142,300 | 677億7600万 | +8.83% |
| 02/03 | 8,150 | 8,340 | 8,060 | 8,310 | +2.72% | 163,600 | 686億8519万 | +11.65% |
| 02/02 | 7,910 | 8,240 | 7,840 | 8,090 | +2.28% | 156,500 | 668億6681万 | +10.19% |
| 01/30 | 7,890 | 8,010 | 7,740 | 7,910 | -1.49% | 89,000 | 653億7904万 | +9.04% |
| 01/29 | 7,830 | 8,240 | 7,830 | 8,030 | +1.77% | 150,700 | 663億7088万 | +12.01% |
| 01/28 | 7,820 | 7,900 | 7,660 | 7,890 | -0.25% | 104,100 | 652億1373万 | +11.39% |
| 01/27 | 8,070 | 8,070 | 7,760 | 7,910 | -1.13% | 112,900 | 653億7904万 | +13% |
| 01/26 | 8,030 | 8,060 | 7,780 | 8,000 | +1.01% | 118,900 | 661億2292万 | +15.56% |
| 01/23 | 7,690 | 8,080 | 7,590 | 7,920 | +4.62% | 203,000 | 654億6169万 | +15.69% |
| 01/22 | 7,770 | 7,910 | 7,480 | 7,570 | +3.42% | 268,100 | 625億6882万 | +11.75% |
| 01/21 | 16:00 当社所属研究者による心筋再生研究に関する論文のScienceへの掲載及びNature Cardiovascular Researchにおいて重要論文として評価を受けたことに関するお知らせ |
| 01/21 | 7,900 | 8,070 | 7,300 | 7,320 | -9.07% | 348,100 | 604億8344万 | +8.99% |
| 01/20 | 8,390 | 8,430 | 7,970 | 8,050 | -4.28% | 156,900 | 665億1526万 | +20.83% |
| 01/19 | 8,040 | 8,550 | 7,940 | 8,410 | +4.6% | 204,500 | 694億8986万 | +27.64% |
| 01/16 | 8,700 | 8,710 | 7,820 | 8,040 | -6.84% | 445,900 | 664億3263万 | +23.77% |
| 01/15 | 8,000 | 8,700 | 7,920 | 8,630 | +6.54% | 327,900 | 713億767万 | +34.47% |
| 01/14 | 7,580 | 8,100 | 7,490 | 8,100 | +5.74% | 286,200 | 669億2840万 | +28.25% |
| 01/13 | 7,440 | 7,700 | 7,260 | 7,660 | +5.8% | 210,700 | 632億9278万 | +22.84% |
| 01/09 | 7,110 | 7,280 | 6,930 | 7,240 | +0.84% | 192,200 | 598億2242万 | +17.28% |
| 01/08 | 6,840 | 7,210 | 6,740 | 7,180 | +7.81% | 226,800 | 593億2665万 | +17.19% |
| 01/07 | 6,740 | 6,750 | 6,540 | 6,660 | -1.48% | 131,200 | 550億3002万 | +9.45% |
| 01/06 | 6,300 | 6,830 | 6,280 | 6,760 | +8.68% | 234,300 | 558億5629万 | +11.37% |
| 01/05 | 6,070 | 6,250 | 6,030 | 6,220 | +3.15% | 71,600 | 513億9440万 | +2.66% |
| 2025 |
| 12/30 | 6,220 | 6,250 | 6,020 | 6,030 | -3.21% | 70,100 | 498億2447万 | -0.59% |
| 12/29 | 6,080 | 6,420 | 6,060 | 6,230 | +3.66% | 122,700 | 514億7703万 | +2.67% |
| 12/26 | 5,930 | 6,010 | 5,930 | 6,010 | +1.86% | 84,300 | 496億5922万 | -0.91% |
| 12/25 | 5,790 | 5,940 | 5,790 | 5,900 | +1.9% | 72,100 | 487億5031万 | -2.83% |
| 12/24 | 5,880 | 5,930 | 5,780 | 5,790 | -1.53% | 70,600 | 478億4141万 | -4.8% |
| 12/23 | 5,750 | 5,900 | 5,730 | 5,880 | +1.55% | 88,800 | 485億8506万 | -3.57% |
| 12/22 | 5,890 | 5,930 | 5,770 | 5,790 | -1.7% | 80,900 | 478億2694万 | -5.38% |
| 12/19 | 5,810 | 5,940 | 5,800 | 5,890 | +1.38% | 74,300 | 486億5296万 | -4.17% |
| 12/18 | 5,920 | 5,950 | 5,810 | 5,810 | -2.84% | 93,200 | 479億9214万 | -5.91% |
| 12/17 | 6,070 | 6,090 | 5,920 | 5,980 | -1.48% | 80,400 | 493億9639万 | -3.75% |
| 12/16 | 6,140 | 6,140 | 6,030 | 6,070 | -0.82% | 51,800 | 501億3981万 | -2.69% |
| 12/15 | 6,080 | 6,150 | 6,050 | 6,120 | -0.16% | 39,100 | 505億5282万 | -2.11% |
| 12/12 | 5,990 | 6,160 | 5,990 | 6,130 | +2.51% | 67,400 | 506億3543万 | -2.14% |
| 12/11 | 6,230 | 6,230 | 5,980 | 5,980 | -3.7% | 83,300 | 493億9639万 | -4.75% |
| 12/10 | 6,130 | 6,240 | 6,120 | 6,210 | +1.8% | 49,600 | 512億9625万 | -1.55% |
| 12/09 | 6,080 | 6,170 | 6,070 | 6,100 | +0.33% | 56,800 | 503億8762万 | -3.59% |
| 12/08 | 6,050 | 6,080 | 5,980 | 6,080 | -0.16% | 67,000 | 502億2241万 | -4.1% |
| 12/05 | 6,070 | 6,100 | 5,940 | 6,090 | +0.16% | 82,600 | 503億501万 | -4.06% |
| 12/04 | 6,060 | 6,160 | 6,060 | 6,080 | -0.16% | 58,900 | 502億2241万 | -4.39% |
| 12/03 | 6,090 | 6,130 | 6,020 | 6,090 | 0% | 48,900 | 503億501万 | -4.35% |
| 12/02 | 6,150 | 6,220 | 6,070 | 6,090 | -0.81% | 49,200 | 503億501万 | -4.53% |
| 12/01 | 6,330 | 6,340 | 6,100 | 6,140 | -2.23% | 74,000 | 507億1803万 | -4% |
| 11/28 | 6,430 | 6,500 | 6,280 | 6,280 | -3.09% | 53,500 | 518億7447万 | -2.13% |
| 11/27 | 6,450 | 6,490 | 6,410 | 6,480 | +1.09% | 37,300 | 535億2652万 | +0.65% |
| 11/26 | 6,070 | 6,430 | 6,070 | 6,410 | +5.43% | 84,400 | 529億4830万 | -0.62% |
| 11/25 | 6,160 | 6,180 | 6,050 | 6,080 | -1.14% | 65,000 | 502億2241万 | -5.85% |
| 11/21 | 6,120 | 6,190 | 6,090 | 6,150 | -0.65% | 61,200 | 508億63万 | -5% |
| 11/20 | 6,170 | 6,250 | 6,130 | 6,190 | +0.98% | 66,100 | 510億5181万 | -4.71% |
| 11/19 | 6,160 | 6,260 | 6,050 | 6,130 | -1.13% | 83,900 | 505億5696万 | -5.98% |
| 11/18 | 6,400 | 6,490 | 6,200 | 6,200 | -3.28% | 86,100 | 511億3428万 | -5.23% |
| 11/17 | 12:15 積水化学グループが細胞安定供給製造バリューチェーンコンソーシアム（VMaCS）に参画 |
| 11/17 | 6,520 | 6,520 | 6,370 | 6,410 | -0.93% | 64,200 | 528億6625万 | -2.47% |
| 11/14 | 6,500 | 6,630 | 6,370 | 6,470 | -1.97% | 90,100 | 533億6110万 | -1.93% |
| 11/13 | 15:30 2026年3月期第2四半期決算説明資料 |
| 11/13 | 15:30 2026年3月期第2四半期(中間期)決算短信〔日本基準〕(連結) |
| 11/13 | 6,760 | 6,790 | 6,590 | 6,600 | -2.37% | 72,600 | 544億3327万 | -0.41% |
| 11/12 | 6,600 | 6,820 | 6,590 | 6,760 | +2.42% | 96,900 | 557億5287万 | +1.61% |
| 11/11 | 6,460 | 6,600 | 6,430 | 6,600 | +2.64% | 51,900 | 544億3327万 | -1.11% |
| 11/10 | 6,370 | 6,480 | 6,370 | 6,430 | +0.16% | 24,100 | 530億3120万 | -3.97% |
| 11/07 | 6,400 | 6,490 | 6,330 | 6,420 | -0.93% | 68,400 | 529億4873万 | -4.29% |
| 11/06 | 6,730 | 6,800 | 6,470 | 6,480 | -3.71% | 73,300 | 534億4357万 | -3.6% |
| 11/05 | 6,560 | 6,740 | 6,400 | 6,730 | +0.6% | 109,900 | 555億544万 | -0.18% |
| 11/04 | 17:00 第6回新株予約権(税制適格ストック・オプション)の発行内容確定に関するお知らせ |
| 11/04 | 6,460 | 6,850 | 6,380 | 6,690 | +4.37% | 121,700 | 551億7554万 | -1.06% |
| 10/31 | 6,260 | 6,420 | 6,260 | 6,410 | +1.91% | 66,000 | 528億6625万 | -5.53% |
| 10/30 | 6,320 | 6,370 | 6,280 | 6,290 | -1.26% | 70,200 | 518億7656万 | -7.69% |
| 10/29 | 6,510 | 6,660 | 6,330 | 6,370 | +1.43% | 176,900 | 525億3635万 | -7.01% |
| 10/28 | 15:30 「ヒト(同種)iPS細胞由来心筋細胞シート」の希少疾病用再生医療等製品指定に関するお知らせ |
| 10/28 | 6,320 | 6,370 | 6,210 | 6,280 | -1.57% | 82,500 | 517億9408万 | -8.8% |
| 10/27 | 6,500 | 6,570 | 6,360 | 6,380 | -2.3% | 88,800 | 526億1883万 | -7.84% |
| 10/24 | 6,630 | 6,660 | 6,520 | 6,530 | -1.95% | 81,600 | 538億5595万 | -6.06% |
| 10/23 | 6,720 | 6,770 | 6,660 | 6,660 | -1.91% | 44,300 | 549億2812万 | -4.56% |
| 10/22 | 6,740 | 6,850 | 6,740 | 6,790 | +0.15% | 46,500 | 560億29万 | -3.15% |
| 10/21 | 6,610 | 6,800 | 6,550 | 6,780 | +2.26% | 73,100 | 559億425万 | -3.68% |
| 10/20 | 6,460 | 6,670 | 6,460 | 6,630 | +2.31% | 75,900 | 546億6743万 | -6.22% |
| 10/17 | 15:30 第6回新株予約権(税制適格ストック・オプション)の発行に関するお知らせ |
| 10/17 | 6,630 | 6,660 | 6,410 | 6,480 | -2.99% | 150,400 | 534億3061万 | -8.75% |
| 10/16 | 6,770 | 6,830 | 6,680 | 6,680 | -1.62% | 75,500 | 550億7971万 | -6.43% |
| 10/15 | 6,750 | 6,840 | 6,720 | 6,790 | +1.49% | 61,900 | 559億8671万 | -5.25% |
| 10/14 | 6,840 | 6,960 | 6,640 | 6,690 | -3.6% | 148,200 | 551億6216万 | -6.89% |
| 10/10 | 16:00 レグセル株式会社創業研究者 坂口志文博士 ノーベル生理学・医学賞受賞について |
| 10/10 | 7,010 | 7,090 | 6,920 | 6,940 | -1.42% | 112,900 | 572億2353万 | -3.53% |
| 10/09 | 7,180 | 7,230 | 7,040 | 7,040 | -2.63% | 94,100 | 580億4808万 | -2.22% |
| 10/08 | 7,230 | 7,240 | 7,150 | 7,230 | -0.28% | 58,200 | 596億1471万 | +0.28% |
| 10/07 | 7,350 | 7,430 | 7,210 | 7,250 | -0.55% | 126,400 | 597億7962万 | +0.46% |
10年以上蓄積したファイナンスデータとAIを掛け合わせて、投資の意思決定を加速させるポジションです。
